Chenodeoxycholic Acid Enhances the Effect of Sorafenib in Inhibiting HepG2 Cell Growth Through EGFR/Stat3 Pathway
Yang Zhang(Beijing University of Chinese Medicine), Yunliang Wang(Beijing University of Chinese Medicine)
Cited by 11
Related Papers
Loss of NDUFS1 promotes gastric cancer progression by activating the mitochondrial ROS-HIF1α-FBLN5 signaling pathway
|British Journal of Cancer|2023|49